Business Wire
22 Aug 2026, 08:43 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Bio-Techne Corporation (NASDAQ: TECH) is being acquired by Merck KGaA for $73.00 per share in cash. — A definitive cash acquisition price typically creates a price floor and provides immediate value realization for shareholders.
+0.80Law firm Halper Sadeh LLC is investigating whether Bio-Techne and its board violated fiduciary duties regarding the sale. — Shareholder litigation is common in M&A and usually causes minor friction or delays rather than deal collapse.
-0.20Which stocks this story touches
The company is the subject of a legal investigation regarding the terms of its sale.
Continue reading
6 related stories
Search tags
[a_to_b] Merck KGaA is acquiring Bio-Techne Corporation for $73.00 per share.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
5h ago
